Search results
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 1 day agoWhat Do Annual Metrics Say? Moderna stock went public at 23 in late 2018. In 2020, shares rocketed...
3 Short-Squeeze Stocks Ready to Break the Chains of Bearish Sentiment
InvestorPlace· 3 days agoIt was not long ago that Novavax (NASDAQ:NVAX) was among the stocks with high short interest. In the...
Why 93% Of This Biotech's Value Just Went Up In Smoke
Investor's Business Daily· 4 days agoWedbush analyst Laura Chico slashed her price target on Aerovatestock to 3 from 41, calling the...
Cramer's Lightning Round: 'Let's stay away' from Unity Software
CNBC· 7 days ago"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 7 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...
Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day...
Benzinga· 3 days agoShares of Quantum Corporation QMCO fell sharply during Tuesday's session after the company reported...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks· 7 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved non-inferior vaccine efficacy against COVID-19 when compared with its previously approved bivalent COVID-19 vaccine.